These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Nephrotic syndrome and adrenal insufficiency caused by a variant in Linhares ND; Arantes RR; Araujo SA; Pena SDJ Clin Kidney J; 2018 Aug; 11(4):462-467. PubMed ID: 30090628 [TBL] [Abstract][Full Text] [Related]
32. Sphingolipid biosynthesis in man and microbes. Harrison PJ; Dunn TM; Campopiano DJ Nat Prod Rep; 2018 Sep; 35(9):921-954. PubMed ID: 29863195 [TBL] [Abstract][Full Text] [Related]
33. First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells. Engel N; Adamus A; Frank M; Kraft K; Kühn J; Müller P; Nebe B; Kasten A; Seitz G PLoS One; 2018; 13(5):e0196854. PubMed ID: 29718989 [TBL] [Abstract][Full Text] [Related]
34. Nuclear Translocation of SGPP-1 and Decrease of SGPL-1 Activity Contribute to Sphingolipid Rheostat Regulation of Inflammatory Dendritic Cells. Schwiebs A; Thomas D; Kleuser B; Pfeilschifter JM; Radeke HH Mediators Inflamm; 2017; 2017():5187368. PubMed ID: 29375197 [TBL] [Abstract][Full Text] [Related]
35. Endogenous Sphingolipid Signaling Pathway Implicated in the Action of Croton membranaceus on the Prostate Gland in BPH Patients. Asare GA; Anang Y; Afriyie DK; Amoah BY; Asiedu B; Doku D; Ocansey HS; Odei Danso NY; Tekpor P; Osam S Medicines (Basel); 2017 Nov; 4(4):. PubMed ID: 29156544 [No Abstract] [Full Text] [Related]
36. Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential. Meshcheryakova A; Mechtcheriakova D; Pietschmann P Expert Opin Ther Targets; 2017 Jul; 21(7):725-737. PubMed ID: 28524744 [TBL] [Abstract][Full Text] [Related]
37. Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications. Janecke AR; Xu R; Steichen-Gersdorf E; Waldegger S; Entenmann A; Giner T; Krainer I; Huber LA; Hess MW; Frishberg Y; Barash H; Tzur S; Schreyer-Shafir N; Sukenik-Halevy R; Zehavi T; Raas-Rothschild A; Mao C; Müller T Hum Mutat; 2017 Apr; 38(4):365-372. PubMed ID: 28181337 [TBL] [Abstract][Full Text] [Related]
38. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. Prasad R; Hadjidemetriou I; Maharaj A; Meimaridou E; Buonocore F; Saleem M; Hurcombe J; Bierzynska A; Barbagelata E; Bergadá I; Cassinelli H; Das U; Krone R; Hacihamdioglu B; Sari E; Yesilkaya E; Storr HL; Clemente M; Fernandez-Cancio M; Camats N; Ram N; Achermann JC; Van Veldhoven PP; Guasti L; Braslavsky D; Guran T; Metherell LA J Clin Invest; 2017 Mar; 127(3):942-953. PubMed ID: 28165343 [TBL] [Abstract][Full Text] [Related]
39. Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis. Billich A; Baumruker T; Beerli C; Bigaud M; Bruns C; Calzascia T; Isken A; Kinzel B; Loetscher E; Metzler B; Mueller M; Nuesslein-Hildesheim B; Kleylein-Sohn B PLoS One; 2013; 8(3):e59630. PubMed ID: 23544080 [TBL] [Abstract][Full Text] [Related]
40. PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism. Bourquin F; Capitani G; Grütter MG Protein Sci; 2011 Sep; 20(9):1492-508. PubMed ID: 21710479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]